BR112015002727B1 - Combinação, composição farmacêutica, kit, e, usos de uma combinação, e de uma composição farmacêutica - Google Patents
Combinação, composição farmacêutica, kit, e, usos de uma combinação, e de uma composição farmacêutica Download PDFInfo
- Publication number
- BR112015002727B1 BR112015002727B1 BR112015002727-0A BR112015002727A BR112015002727B1 BR 112015002727 B1 BR112015002727 B1 BR 112015002727B1 BR 112015002727 A BR112015002727 A BR 112015002727A BR 112015002727 B1 BR112015002727 B1 BR 112015002727B1
- Authority
- BR
- Brazil
- Prior art keywords
- dab
- combination
- pharmaceutical composition
- infections
- compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6807—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug or compound being a sugar, nucleoside, nucleotide, nucleic acid, e.g. RNA antisense
- A61K47/6809—Antibiotics, e.g. antitumor antibiotics anthracyclins, adriamycin, doxorubicin or daunomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
- A61L2300/406—Antibiotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12005744.3 | 2012-08-08 | ||
| EP12005744 | 2012-08-08 | ||
| PCT/EP2013/066530 WO2014023757A1 (en) | 2012-08-08 | 2013-08-07 | Combinations with a backbone-cyclized peptide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112015002727A2 BR112015002727A2 (pt) | 2017-08-08 |
| BR112015002727B1 true BR112015002727B1 (pt) | 2022-09-06 |
Family
ID=46796226
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112015002727-0A BR112015002727B1 (pt) | 2012-08-08 | 2013-08-07 | Combinação, composição farmacêutica, kit, e, usos de uma combinação, e de uma composição farmacêutica |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US9775877B2 (https=) |
| EP (1) | EP2882770B1 (https=) |
| JP (2) | JP6486270B2 (https=) |
| KR (1) | KR102167324B1 (https=) |
| CN (1) | CN104684925B (https=) |
| AU (1) | AU2013301567B2 (https=) |
| BR (1) | BR112015002727B1 (https=) |
| CA (1) | CA2879207C (https=) |
| CY (1) | CY1119308T1 (https=) |
| DK (1) | DK2882770T3 (https=) |
| EA (1) | EA030077B1 (https=) |
| ES (1) | ES2639165T3 (https=) |
| HR (1) | HRP20171299T1 (https=) |
| HU (1) | HUE035891T2 (https=) |
| IL (1) | IL236697B (https=) |
| LT (1) | LT2882770T (https=) |
| MX (2) | MX366997B (https=) |
| NZ (1) | NZ703729A (https=) |
| PL (1) | PL2882770T3 (https=) |
| PT (1) | PT2882770T (https=) |
| RS (1) | RS56249B1 (https=) |
| SG (1) | SG11201500216TA (https=) |
| SI (1) | SI2882770T1 (https=) |
| WO (1) | WO2014023757A1 (https=) |
| ZA (1) | ZA201500278B (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2132221T3 (pl) | 2007-02-28 | 2011-04-29 | Polyphor Ltd | Przyłączone do matrycy peptydomimetyki |
| EP2882770B1 (en) * | 2012-08-08 | 2017-05-31 | Polyphor AG | Combinations with a backbone-cyclized peptide |
| JP2023549971A (ja) * | 2020-11-23 | 2023-11-29 | スペクシス アーゲー | ベータヘアピン型ペプチド模倣物の組成物及びそのエアロゾル投与形態 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2527339T3 (es) | 2001-02-23 | 2015-01-23 | Polyphor Ltd. | Peptidomiméticos fijados a patrón con actividad antimicrobiana |
| JP4221368B2 (ja) | 2002-08-20 | 2009-02-12 | ポリファー リミテッド | 抗菌活性を有するテンプレート結合ペプチド擬似体 |
| WO2007079597A1 (en) * | 2006-01-16 | 2007-07-19 | Polyphor Ltd. | Template - fixed peptidomimetics with antimicrobial activity |
| PL2132221T3 (pl) * | 2007-02-28 | 2011-04-29 | Polyphor Ltd | Przyłączone do matrycy peptydomimetyki |
| WO2010017273A2 (en) * | 2008-08-06 | 2010-02-11 | Wyeth | Tigecycline formulations |
| EP2882770B1 (en) * | 2012-08-08 | 2017-05-31 | Polyphor AG | Combinations with a backbone-cyclized peptide |
-
2013
- 2013-08-07 EP EP13745432.8A patent/EP2882770B1/en active Active
- 2013-08-07 LT LTEP13745432.8T patent/LT2882770T/lt unknown
- 2013-08-07 DK DK13745432.8T patent/DK2882770T3/en active
- 2013-08-07 MX MX2015001685A patent/MX366997B/es active IP Right Grant
- 2013-08-07 CN CN201380041532.3A patent/CN104684925B/zh not_active Expired - Fee Related
- 2013-08-07 EA EA201590351A patent/EA030077B1/ru unknown
- 2013-08-07 CA CA2879207A patent/CA2879207C/en active Active
- 2013-08-07 NZ NZ703729A patent/NZ703729A/en not_active IP Right Cessation
- 2013-08-07 PT PT137454328T patent/PT2882770T/pt unknown
- 2013-08-07 BR BR112015002727-0A patent/BR112015002727B1/pt not_active IP Right Cessation
- 2013-08-07 WO PCT/EP2013/066530 patent/WO2014023757A1/en not_active Ceased
- 2013-08-07 US US14/419,986 patent/US9775877B2/en not_active Expired - Fee Related
- 2013-08-07 SG SG11201500216TA patent/SG11201500216TA/en unknown
- 2013-08-07 PL PL13745432T patent/PL2882770T3/pl unknown
- 2013-08-07 SI SI201330760T patent/SI2882770T1/sl unknown
- 2013-08-07 RS RS20170862A patent/RS56249B1/sr unknown
- 2013-08-07 HR HRP20171299TT patent/HRP20171299T1/hr unknown
- 2013-08-07 ES ES13745432.8T patent/ES2639165T3/es active Active
- 2013-08-07 AU AU2013301567A patent/AU2013301567B2/en not_active Ceased
- 2013-08-07 JP JP2015525873A patent/JP6486270B2/ja not_active Expired - Fee Related
- 2013-08-07 KR KR1020157005848A patent/KR102167324B1/ko active Active
- 2013-08-07 HU HUE13745432A patent/HUE035891T2/en unknown
-
2015
- 2015-01-13 IL IL236697A patent/IL236697B/en active IP Right Grant
- 2015-01-14 ZA ZA2015/00278A patent/ZA201500278B/en unknown
- 2015-02-06 MX MX2019002657A patent/MX2019002657A/es unknown
-
2017
- 2017-08-28 CY CY20171100902T patent/CY1119308T1/el unknown
-
2018
- 2018-01-04 JP JP2018000089A patent/JP2018087191A/ja not_active Withdrawn
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Dartois et al. | Systemic antibacterial activity of novel synthetic cyclic peptides | |
| CN106232616B (zh) | 两亲性合成抗菌肽、其药物组合物及其用途 | |
| BR112016030580B1 (pt) | Polipeptídeo de lisina e fragmento de polipeptídeo com atividade para matar bactérias gram-negativas | |
| BR112015002727B1 (pt) | Combinação, composição farmacêutica, kit, e, usos de uma combinação, e de uma composição farmacêutica | |
| DK2882771T3 (en) | COMBINATIONS WITH A BACKBONE CYCLIZED PEPTID | |
| HK1207866B (zh) | 含有主链环化肽的组合 | |
| HK1207868B (en) | Combinations with a backbone-cyclized peptide | |
| BR112017014670B1 (pt) | Derivado de polimixina e usos do mesmo |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06I | Publication of requirement cancelled [chapter 6.9 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA. |
|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NAO 10196/2001, QUE MODIFICOU A LEI NAO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUAANCIA PRA VIA DA ANVISA. CONSIDERANDO A APROVAA AO DOS TERMOS DO PARECER NAO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NAO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDAANCIAS CABA-VEIS. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 07/08/2013, OBSERVADAS AS CONDICOES LEGAIS |
|
| B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 12A ANUIDADE. |
|
| B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2845 DE 15-07-2025 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |